Legal Representation
Attorney
Ronald M. Kachmarik
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 23, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2025 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Dec 17, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 3, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 2, 2025 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Nov 21, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 19, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 19, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 19, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 5, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 16, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 16, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 9, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 8, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 30, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 19, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Mar 21, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 21, 2025 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Feb 27, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products and preparations for the diagnosis, prevention and treatment of oncological, haematological, immunological and infectious diseases, and for xenotransplantation; polyclonal antibodies for medical, pharmaceutical and veterinary use; monoclonal antibodies for medical, pharmaceutical and veterinary use; diagnostic preparations and diagnostic biomarker reagents for medical use; chemical and biological preparations for medical or pharmaceutical use, for the diagnosis, prevention and treatment of oncological, haematological, immunological and infectious diseases, and for xenotransplantation; chemical reagents for medical or veterinary use
Classification
International Classes
005